PMID- 25938134 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220408 IS - 2373-2822 (Electronic) IS - 2373-2822 (Linking) VI - 2 IP - 2 DP - 2015 Feb 28 TI - Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses. LID - e0029-14.2015 [pii] LID - ENEURO.0029-14.2015 AB - The endogenous cannabinoid (endocannabinoid) system is an important regulator of synaptic function. Endocannabinoids acutely modulate inhibitory and excitatory transmission, and also mediate long-term depression at GABAergic and glutamatergic synapses. Typically, endocannabinoid synthesis and release is stimulated by depolarization-induced calcium influx and/or activation of phospholipase-C (PLC) signaling triggered by mGluR activation. Recently it has been shown that brain-derived neurotrophic factor (BDNF) can also induce endocannabinoid release. Although there is growing evidence for cross-talk between BDNF and endocannabinoid signaling, little is known about the functional relevance of these interactions. In the present studies, we examined BDNF - endocannabinoid interactions in regulating activity-dependent long-term depression at inhibitory synapses (iLTD). We found that theta burst stimulation (TBS) in layer 2/3 of mouse somatosensory cortical slices can induce a form of endocannabinoid-mediated iLTD that is independent of metabotropic glutamate receptor (mGluR) activation. This endocannabinoid-dependent iLTD, however, requires endogenous BDNF-trkB signaling, as it is blocked by a trk tyrosine kinase inhibitor and by a trkB receptor antagonist, and also requires activation of diacylglycerol lipase (DAG-lipase, DGL). In addition, endocannabinoid-mediated iLTD can be induced by combining a subthreshold concentration of exogenous BDNF with weak TBS stimulation that by itself is insufficient to induce iLTD. Taken together, our results suggest that TBS can induce the release of endogenous BDNF, which triggers DGL-dependent endocannabinoid mobilization and cannabinoid receptor-dependent iLTD at layer 2/3 cortical synapses. FAU - Zhao, Liangfang AU - Zhao L AD - Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut 06030. FAU - Yeh, Mason Li-Wen AU - Yeh ML AD - Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut 06030. FAU - Levine, Eric S AU - Levine ES AD - Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut 06030. LA - eng GR - R01 MH094896/MH/NIMH NIH HHS/United States PT - Journal Article PL - United States TA - eNeuro JT - eNeuro JID - 101647362 PMC - PMC4415885 MID - NIHMS684239 OTO - NOTNLM OT - BDNF OT - CB1 OT - endocannabinoid OT - inhibitory OT - long-term depression OT - trkB COIS- Authors report no conflict of interest. EDAT- 2015/05/06 06:00 MHDA- 2015/05/06 06:01 PMCR- 2015/04/01 CRDT- 2015/05/05 06:00 PHST- 2015/05/05 06:00 [entrez] PHST- 2015/05/06 06:00 [pubmed] PHST- 2015/05/06 06:01 [medline] PHST- 2015/04/01 00:00 [pmc-release] AID - e0029-14.2015 [pii] AID - eN-NWR-0029-14 [pii] AID - 10.1523/ENEURO.0029-14.2015 [doi] PST - ppublish SO - eNeuro. 2015 Feb 28;2(2):ENEURO.0029-14.2015. doi: 10.1523/ENEURO.0029-14.2015.